Trace-and-track requirement for pharmaceutical exports mandates GS1 barcode labeling to enable unique product identification and tracing. Exporters must submit a Certificate of Analysis at shipment-issued by the manufacturer, an importing-country approved laboratory, or a laboratory approved under the Drugs and Cosmetics Act-and port Drug Control officials may retain samples for tracking. Exporters are also required to implement GS1 barcode-based trace-and-track across primary, secondary and tertiary packaging, encoding GTIN, batch number, expiry date and serial number to facilitate identification and enforcement of exported pharmaceutical consignments.
Cases where this provision is explicitly mentioned in the judgment/order text; may not be exhaustive. To view the complete list of cases mentioning this section, Click here.
Provisions expressly mentioned in the judgment/order text.
Trace-and-track requirement for pharmaceutical exports mandates GS1 barcode labeling to enable unique product identification and tracing.
Exporters must submit a Certificate of Analysis at shipment-issued by the manufacturer, an importing-country approved laboratory, or a laboratory approved under the Drugs and Cosmetics Act-and port Drug Control officials may retain samples for tracking. Exporters are also required to implement GS1 barcode-based trace-and-track across primary, secondary and tertiary packaging, encoding GTIN, batch number, expiry date and serial number to facilitate identification and enforcement of exported pharmaceutical consignments.
Full Summary is available for active users!
Note: It is a system-generated summary and is for quick reference only.
TaxTMI 
of 
TaxTMI 
